US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 3.510
  • -0.220-5.90%
Close Nov 11 16:00 ET
  • 3.590
  • +0.080+2.28%
Post 20:02 ET
933.99MMarket Cap-3078P/E (TTM)

Autolus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Autolus Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
155.00K
-61.82%
EPS
-0.22
+16.66%
Analyst Rating
Buy

Nov 11, 2024

Autolus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
Nov 12, 2024 2024/Q3 -- / 155.000K --
Aug 8, 2019 2019/Q2 -- / 500.000K --
Aug 8, 2024 2024/Q2 0.000 / 62.500K --
May 17, 2024 2024/Q1 10.091M / 25.047M --
Mar 14, 2024 2023/Q4 0.000 / 256.000K --
DatePeriodRevenue/EstimateEarnings Call
Nov 12, 20242024/Q3-- / 155.000K--
Aug 8, 20192019/Q2-- / 500.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--
Mar 14, 20242023/Q40.000 / 256.000K--

Unlock Free Earnings Estimates

Autolus Therapeutics Earnings Reports

  • Autolus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:26

  • Autolus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 18 04:44

  • Autolus Therapeutics | 10-K: FY2023 Annual Report

    Mar 22 10:17

  • Autolus Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 10, 2023 05:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data